Clinical approval for tenofovir dipivoxil fumarate, a new drug of Anke in the treatment of AIDS
-
Last Update: 2020-04-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Tenofovir fumarate dipivoxil (tablets) is a nucleotide reverse transcriptase inhibitor, which is mainly used in the treatment of AIDS, hepatitis B and other diseases The drug was first developed by Gilead company in the United States At present, only one original manufacturer of this kind of tablet in China has obtained import registration and marketing According to the notice of approval opinions of the State Food and Drug Administration on tenofovir fumarate Dipivoxil and the approval documents of clinical trials of tenofovir fumarate dipivoxil tablets The dosage form of the drug is approved as API and tablet, and the registration classification is: chemical 3.1 and chemical 3.4 After obtaining the approval for clinical trial of tenofovir dipivoxil fumarate tablets, the company will organize and implement the clinical trial according to the requirements of the national clinical trial, and apply for the production approval of this product after the completion of the clinical trial According to the insiders, there are many uncertainties in the process from clinical trial to formal production with national approval The time is short for several months, long for several years, or even premature.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
